Overview of pharmacogenomic testing in clinical practice

INTRODUCTION: Pharmacogenomic tests relevant to neuropsychiatric medications have been clinically available for more than a decade, but the utility of regular testing is still unknown. Tests available include both pharmacokinetic and pharmacodynamic targets. The potential practice benefits vary with...

Descripción completa

Detalles Bibliográficos
Autores principales: Gross, Tonya, Daniel, Jeremy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: College of Psychiatric & Neurologic Pharmacists 2018
Materias:
Literature Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125117/
https://www.ncbi.nlm.nih.gov/pubmed/30206507
http://dx.doi.org/10.9740/mhc.2018.09.235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125117/
https://www.ncbi.nlm.nih.gov/pubmed/30206507
http://dx.doi.org/10.9740/mhc.2018.09.235

Ejemplares similares